BOPA 2017 | The role of pharmacists when introducing biosimilar monoclonal antibodies into practice
Simon Cheesman
• 7 Oct 2017
During the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium for cancer care pharmacy in Glasgow, UK, Simon Cheesman, BPharm, MRPharmS from the University College London Hospital, London, UK, describes the role of pharmacists when introducing biosimilars into clinical practice based on his experience of biosimilar rituximab.
This content has been supported by Napp Pharmaceuticals through an unrestricted educational grant to Magdalen Medical Publishing. The company has had no influence on the production of the content.
